Research & Treatment
The scientific community is making breakthroughs. Your donations accelerate that progress.
Gene Therapy
The most promising frontier in DMD treatment. Gene therapy aims to deliver a functional copy of the dystrophin gene or repair existing mutations using CRISPR and viral vector technologies. Clinical trials are underway and showing real results.
Exon Skipping
FDA-approved treatments like eteplirsen (Exondys 51) and casimersen use exon-skipping to restore partial dystrophin production. These drugs represent a major step forward, though they help only specific mutation types.
Dystrophin Restoration
Research into micro-dystrophin constructs and stop codon read-through therapies offers hope for broader treatment options across all DMD mutations.
Why Funding Matters
Research takes resources. Clinical trials, laboratory equipment, researcher salaries, and data analysis all require sustained funding. Rare disease research is chronically underfunded compared to more common diseases.
Every donation to Heal DMD helps bridge this gap — funding the work that gives boys like Michael a real chance at a longer, fuller life.
Current Landscape
4+
FDA-approved DMD treatments
50+
Active clinical trials worldwide
CRISPR
Gene editing showing early promise
Now
The time to fund research is today